Evidence map›Paper›PMID 38622733›Full record

ArticleJournal of experimental & clinical cancer research : CR2024

Correction: Targeting of focal adhesion kinase enhances the immunogenic cell death of PEGylated liposome doxorubicin to optimize therapeutic responses of immune checkpoint blockade.

Baoyuan Zhang, Ning Li, Jiaming Gao, Yuxi Zhao, Jun Jiang, Shuang Xie, Cuiping Zhang, Qingyu Zhang, Leo Liu, Zaiqi Wang and 3 more

Open access · goldAbstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of experimental & clinical cancer research : CR, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.2field-weighted citation impact, top 57% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors at 7 institutions in 1 country.

Baoyuan Zhang *State Key Laboratory for Medical Genomics, Collaborative Innovation Center of Hematology, Shanghai Institute of HematologyNational Research Center for Translational Medicine Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Ning Li *Department of Gynecologic Oncology, National Cancer Center, National Clinical Research Center for Cancer/Cancer Hospital, Chinses Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Jiaming Gao *State Key Laboratory for Medical Genomics, Collaborative Innovation Center of Hematology, Shanghai Institute of HematologyNational Research Center for Translational Medicine Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Yuxi ZhaoDepartment of Gynecologic Oncology, National Cancer Center, National Clinical Research Center for Cancer/Cancer Hospital, Chinses Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Jun JiangInxMed (Shanghai) Co., Ltd, Beijing, China.
Shuang XieInxMed (Shanghai) Co., Ltd, Beijing, China.
Cuiping ZhangDepartment of Pathology, Yantai Afliated Hospital of Binzhou Medical University, Yantai, Shandong, China.
Qingyu ZhangLaboratory of Obstetrics and Gynecology, Afliated Hospital of Guangdong Medical University, Zhanjiang, Guangdong, China.
Leo LiuInxMed (Shanghai) Co., Ltd, Beijing, China.
Zaiqi WangInxMed (Shanghai) Co., Ltd, Beijing, China.
Dongmei JiDepartment of Medical Oncology, Fudan University Shanghai Cancer Center, Shanghai, China. jid09@fudan.edu.cn.
Lingying WuDepartment of Gynecologic Oncology, National Cancer Center, National Clinical Research Center for Cancer/Cancer Hospital, Chinses Academy of Medical Sciences and Peking Union Medical College, Beijing, China. wulingying@csco.org.cn.
Ruibao RenState Key Laboratory for Medical Genomics, Collaborative Innovation Center of Hematology, Shanghai Institute of HematologyNational Research Center for Translational Medicine Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China. rbren@sjtu.edu.cn.
Chinese Academy of Medical Sciences & Peking Union Medical College · CNBinzhou University · CNFudan University Shanghai Cancer Center · CNGuangdong Medical College · CNHainan Medical University · CNRuijin Hospital · CNShanghai Institute of Hematology · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID38622733
PMCPMC11020187
OpenAlexW4394851721

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.